Hypotension News and Research

RSS

Bowel care ranks top concern for individuals with spinal cord injury, study shows

Cardiovascular physiology researcher Victoria Claydon's latest study, published in the Journal of Neurotrauma, focuses on the results of her multi-national study, which surveyed almost 300 participants with spinal cord injuries at or above the mid-thoracic level (middle of the chest ).

9 Mar 2018

Experimental treatment improves invisible symptoms of a man with spinal cord injury

An experimental treatment that sends electrical currents through the spinal cord has improved "invisible" yet debilitating side effects for a B.C. man with a spinal cord injury.

19 Feb 2018

FDA approves drug to increase blood pressure in adults with septic or distributive shock

The U.S. Food and Drug Administration today approved Giapreza (angiotensin II) injection for intravenous infusion to increase blood pressure in adults with septic or other distributive shock.

21 Dec 2017

Study provides detailed characterization of neurotoxicity arising from CD19 CAR T-cell therapy

New potential biomarkers and a novel algorithm could help identify patients at increased risk of suffering from severe neurotoxicity after receiving CD19 CAR T-cell therapy. The study extensively characterized common and occasionally fatal side effects of this immunotherapy.

12 Oct 2017

First-ever treatment for Merkel cell carcinoma receives approval in Japan

Merck KGaA, Darmstadt, Germany, and Pfizer Inc. today announced that the Japanese Ministry of Health, Labor, and Welfare (MHLW) has approved BAVENCIO (avelumab, genetically recombinant Injection 200mg/mL for intravenous use) as the first and only treatment indicated for curatively unresectable Merkel cell carcinoma (MCC), a rare and aggressive cancer, in Japan.

27 Sep 2017

Pfizer receives FDA approval for new therapy to treat adults and children with AML

Pfizer Inc. today announced that the U.S. Food and Drug Administration approved MYLOTARG (gemtuzumab ozogamicin) for adults with newly diagnosed CD33-positive acute myeloid leukemia (AML), and adults and children 2 years and older with relapsed or refractory CD33-positive AML.

1 Sep 2017

$Novartis gets FDA approval for novel immunocellular therapy to treat relapsed or refractory B-cell ALL$

Novartis gets FDA approval for novel immunocellular therapy to treat relapsed or refractory B-cell ALL

Novartis announced today that the US Food and Drug Administration has approved Kymriah (tisagenlecleucel) suspension for intravenous infusion, formerly CTL019, the first chimeric antigen receptor T cell (CAR-T) therapy, for the treatment of patients up to 25 years of age with B-cell precursor acute lymphoblastic leukemia (ALL) that is refractory or in second or later relapse.

30 Aug 2017

FDA approves first cell-based gene therapy for use in the United States

The U.S. Food and Drug Administration issued a historic action today making the first gene therapy available in the United States, ushering in a new approach to the treatment of cancer and other serious and life-threatening diseases.

30 Aug 2017

Researchers develop new method to more accurately measure systolic blood pressure

An estimated 1 in 3 U.S. adults have high blood pressure. Blood pressure levels are often assessed by using automatic blood pressure devices.

14 Aug 2017

Experiments in big animals show efficacy of new non-toxic MRI contrast agent

The top causes of death worldwide, ischemic heart diseases and stroke, together with another major source of illness, that is cancer, require proper imaging of blood vessels.

31 Jul 2017

Study recommends revision of current guidelines for assessing orthostatic hypotension

A new study led by Johns Hopkins researchers suggests that testing for the presence of orthostatic hypotension, a form of low blood pressure, be performed within one minute of standing after a person has been lying down.

31 Jul 2017

Diabetes leads to increase in autonomic and small fiber neuropathy

Autonomic and small fiber neuropathy used to be considered rare conditions. But with approximately 30 million Americans affected by diabetes – one of the main underlying causes for these diseases – it's an emerging problem.

13 Jul 2017

Tracking pulse rate before C-section can predict hypotension events, improve maternal health

Doctors often prescribe preventative drugs to women who are to receive spinal blocks while giving birth via a Caesarean section.

11 Jul 2017

Study reveals safety of patient-administered sedatives during mechanical ventilation

New research takes a novel approach to traditional, clinician-only sedative delivery, finding that select critically ill patients can safely self-administer sedatives to manage their anxiety during mechanical ventilation.

3 Jul 2017

Study: Angiotensin II can safely improve blood pressure among critically ill patients with hypotension

Sixty years after Cleveland Clinic researchers first isolated the role of angiotensin II in controlling blood pressure, a new international study led by Cleveland Clinic researchers shows that the compound can safely improve blood pressure among critically ill patients who are experiencing life-threatening hypotension, or low blood pressure.

22 May 2017

EKF Diagnostics expands the distribution of its Procalcitonin LiquiColor® Test into Eastern Europe, Middle East and APAC regions

EKF, announces that it is expanding the distribution of its Procalcitonin LiquiColor Test into Eastern Europe, Middle East and APAC regions.

From EKF Diagnostics 3 May 2017

Researchers use novel phage therapy to treat patient infected with multidrug-resistant bacterium

Scientists and physicians at University of California San Diego School of Medicine, working with colleagues at the U.S. Navy Medical Research Center - Biological Defense Research Directorate, Texas A&M University, a San Diego-based biotech and elsewhere, have successfully used an experimental therapy involving bacteriophages -- viruses that target and consume specific strains of bacteria -- to treat a patient near death from a multidrug-resistant bacterium.

25 Apr 2017

Amgen, UCB present romosozumab Phase 2 results at ENDO 2017

Amgen and UCB today announced results from the fourth year of a Phase 2 study showing the efficacy and safety of a second course of treatment with EVENITY™* (romosozumab), an investigational agent for postmenopausal women with osteoporosis.

3 Apr 2017

Shortage of low blood pressure drug for patients with septic shock linked to elevated risk of death

Patients with septic shock admitted to hospitals affected by the 2011 shortage of the drug norepinephrine had a higher risk of in-hospital death, according to a study published online by JAMA.

21 Mar 2017

Temporary blood pressure drops in middle age may increase risk of dementia in later years

Middle-aged people who experience temporary blood pressure drops that often cause dizziness upon standing up may be at an increased risk of developing cognitive decline and dementia 20 years later, new Johns Hopkins Bloomberg School of Public Health research suggests.

10 Mar 2017